GlassScriptPhysician profile
Joseph L Walkiewicz
NPI 1396716544
$6,936.00
in general payments reported to CMS, 2019-2025
15 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,911 · 2020: $138 · 2021: $1,735 · 2022: $511 · 2023: $189 · 2024: $274 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,665.39 | 2019-2023 | |
| Arthrex, INC. | $2,460.00 | 2019-2022 | |
| Depuy Synthes Sales INC. | $624.73 | 2019-2025 | Va-Lcp, Na |
| Stryker Corporation | $153.45 | 2020-2023 | Mako, Triathlon |
| Sanara Medtech INC. | $153.29 | 2024 | Celleraterx |
| Smith+Nephew, INC. | $141.29 | 2021 | |
| Zimmer Biomet Holdings, INC. | $136.42 | 2021 | |
| Vericel Corporation | $120.00 | 2022 | |
| Inari Medical, INC. | $119.30 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pacira Therapeutics, INC. | $106.92 | 2019 | |
| Medacta USA, INC. | $93.33 | 2021 | |
| Baxter Healthcare | $57.42 | 2019-2020 | |
| Microport Orthopedics INC | $54.99 | 2025 | Mpo Medial Pivot Knee |
| Pacira Pharmaceuticals Incorporated | $33.62 | 2023-2024 | Iovera, Exparel, Zilretta |
| Bioventus LLC | $15.85 | 2023 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Walkiewicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.